ES2183665A1 - Dna segments that are useful for selecting differentiated cell types and the applications thereof - Google Patents

Dna segments that are useful for selecting differentiated cell types and the applications thereof

Info

Publication number
ES2183665A1
ES2183665A1 ES009902251A ES9902251A ES2183665A1 ES 2183665 A1 ES2183665 A1 ES 2183665A1 ES 009902251 A ES009902251 A ES 009902251A ES 9902251 A ES9902251 A ES 9902251A ES 2183665 A1 ES2183665 A1 ES 2183665A1
Authority
ES
Spain
Prior art keywords
cell types
differentiated cell
useful
applications
dna segments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009902251A
Other languages
Spanish (es)
Other versions
ES2183665B1 (en
Inventor
Abril Alfonso Valera
Belda Josefa Maria Mayol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Miguel Hernandez de Elche UMH
Original Assignee
Universidad Miguel Hernandez de Elche UMH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Miguel Hernandez de Elche UMH filed Critical Universidad Miguel Hernandez de Elche UMH
Priority to ES200102125A priority Critical patent/ES2208024B1/en
Priority to ES9902251A priority patent/ES2183665B1/en
Priority to AU77913/00A priority patent/AU7791300A/en
Priority to PCT/ES2000/000391 priority patent/WO2001027266A1/en
Publication of ES2183665A1 publication Critical patent/ES2183665A1/en
Application granted granted Critical
Publication of ES2183665B1 publication Critical patent/ES2183665B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays

Abstract

The DNA segment comprises: (i) the regions contributing to forming and stabilizing the transcription factor complex of a cell type which is specifically expressed in one differentiated cell type and (ii) a selection gene that is functionally connected so that it is expressed when the DNA segment is recognized and transcribed by the transcription factor complex of the specific gene. The AND segment can be used to obtain and select in vitro differentiated cell types from precursor cells. Cell and tissue banks for therapeutic or research purposes can be created with the cell types obtained.
ES9902251A 1999-10-14 1999-10-14 USEFUL DNA SEGMENTS TO SELECT DIFFERENTIATED CELLULAR TYPES AND THEIR APPLICATIONS. Expired - Fee Related ES2183665B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES200102125A ES2208024B1 (en) 1999-10-14 1999-10-14 A METHOD FOR OBTAINING IN VITRO MOTHER CELLS OF INDIVIDUAL MAMMALS ADULTS.
ES9902251A ES2183665B1 (en) 1999-10-14 1999-10-14 USEFUL DNA SEGMENTS TO SELECT DIFFERENTIATED CELLULAR TYPES AND THEIR APPLICATIONS.
AU77913/00A AU7791300A (en) 1999-10-14 2000-10-13 Dna segments that are useful for selecting differentiated cell types and the applications thereof
PCT/ES2000/000391 WO2001027266A1 (en) 1999-10-14 2000-10-13 Dna segments that are useful for selecting differentiated cell types and the applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9902251A ES2183665B1 (en) 1999-10-14 1999-10-14 USEFUL DNA SEGMENTS TO SELECT DIFFERENTIATED CELLULAR TYPES AND THEIR APPLICATIONS.

Publications (2)

Publication Number Publication Date
ES2183665A1 true ES2183665A1 (en) 2003-03-16
ES2183665B1 ES2183665B1 (en) 2004-08-01

Family

ID=8310234

Family Applications (2)

Application Number Title Priority Date Filing Date
ES200102125A Expired - Fee Related ES2208024B1 (en) 1999-10-14 1999-10-14 A METHOD FOR OBTAINING IN VITRO MOTHER CELLS OF INDIVIDUAL MAMMALS ADULTS.
ES9902251A Expired - Fee Related ES2183665B1 (en) 1999-10-14 1999-10-14 USEFUL DNA SEGMENTS TO SELECT DIFFERENTIATED CELLULAR TYPES AND THEIR APPLICATIONS.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES200102125A Expired - Fee Related ES2208024B1 (en) 1999-10-14 1999-10-14 A METHOD FOR OBTAINING IN VITRO MOTHER CELLS OF INDIVIDUAL MAMMALS ADULTS.

Country Status (3)

Country Link
AU (1) AU7791300A (en)
ES (2) ES2208024B1 (en)
WO (1) WO2001027266A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994024274A1 (en) * 1993-04-21 1994-10-27 The University Of Edinburgh Isolation, selection and propagation of animal transgenic stem cells
WO1998035022A1 (en) * 1997-02-06 1998-08-13 Osiris Therapeutics, Inc. p21?CIP1 OR p27KIP1¿ EFFECTS ON THE REGULATION OF DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS
WO1998044142A1 (en) * 1997-04-01 1998-10-08 The General Hospital Corporation Molecular marker for muscle stem cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401380D0 (en) * 1994-01-25 1994-03-23 Pharmaceutical Proteins Ltd Embryonic cell isolation
US5753506A (en) * 1996-05-23 1998-05-19 Cns Stem Cell Technology, Inc. Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
AU729377B2 (en) * 1997-10-23 2001-02-01 Asterias Biotherapeutics, Inc. Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994024274A1 (en) * 1993-04-21 1994-10-27 The University Of Edinburgh Isolation, selection and propagation of animal transgenic stem cells
WO1998035022A1 (en) * 1997-02-06 1998-08-13 Osiris Therapeutics, Inc. p21?CIP1 OR p27KIP1¿ EFFECTS ON THE REGULATION OF DIFFERENTIATION OF HUMAN MESENCHYMAL STEM CELLS
WO1998044142A1 (en) * 1997-04-01 1998-10-08 The General Hospital Corporation Molecular marker for muscle stem cells

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HERRERA, P.L. et al. "Two transgenic approaches to define the cell lineages in endocrine pancreas development", MOLECULAR AND CELULAR ENDOCRINOLOGY, 1998, Vol. 140, pßginas 45-50. Todo el documento. *
JUN-HSIANG, L. et al. "A tissue-specific promoter that can drive a foreign gene to express in the suprabasal urothelial cells of transgenic mice", PROC. NATL. ACAD. SCI. USA, 1995, Vol. 92, pßginas 679-683. Todo el documento. *

Also Published As

Publication number Publication date
ES2208024B1 (en) 2005-10-01
AU7791300A (en) 2001-04-23
ES2208024A1 (en) 2004-06-01
ES2183665B1 (en) 2004-08-01
WO2001027266A1 (en) 2001-04-19

Similar Documents

Publication Publication Date Title
IL148512A0 (en) Methods for making recombinant proteins using apoptosis inhibitors
IL148152A0 (en) Sequence-specific dna recombination in eukaryotic cells
WO2003025149A8 (en) Cell populations which co-express cd49c and cd90
IL149175A0 (en) Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
DE69940525D1 (en) PREPARATIONS CONTAINING A ZELEXTRACT FOR THE PRODUCTION OF A CELL-FREE PROTEIN AND DEVICE FOR PRODUCING A CELL-FREE PROTEIN
NZ712789A (en) Placental stem cell populations
WO2003023015A3 (en) Method for expression of small antiviral rna molecules within a cell
NO972171L (en) Regulation of neural stem cell proliferation
NZ514025A (en) Compositions and methods for the modification of gene transcription
EP1180932A4 (en) Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
EP1762614A3 (en) Tumor-specific promoters
ES2183665A1 (en) Dna segments that are useful for selecting differentiated cell types and the applications thereof
WO2004013313A3 (en) Antisense nucleic acids
WO2003029453A3 (en) Induction of gene expression by silencing of repressor genes
WO2002100898A3 (en) Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
AU2002224554A1 (en) Cytochrome b5 gene and protein of candida tropicalis and methods relating thereto
CN107598159B (en) A kind of noble metal nanometer material and its application with nitric oxide synthase activity
WO2003099228A3 (en) Compositions and processes for inhibiting gene expression using polynucleotides
AU4816201A (en) Production of tcr gamma delta t cells
AU1539801A (en) Transcription factors containing two potential dna binding motifs
ATE341630T1 (en) USE OF PANCREATIC PROCARBOXYPEPTIDASE B FOR PRODUCING INSULIN
EP1870470A3 (en) Method and kit for expressing protein under regulation of the expression from repeated sequence formed by gene amplification and transformant
AU6077599A (en) Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1)
BR0014489B1 (en) adenovirus production process and kit.
WO2001034818A3 (en) Sorghum dwarfing genes and methods of use

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030316

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2183665B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20200124